Log in | Register

Blogs

Loading...
The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Seven Success Criteria for Hiring (and working with) a Good GMP Consultant

Seven Success Criteria for Hiring (and working with) a Good GMP Consultant

Apr 16 | The QA Pharm

The high layoff numbers in the pharmaceutical industry and poor job prospects in a weak economy have flooded the market with would-be consultants to pharma companies that need extra help. Here are my suggestions for hiring and working with a good GMP consultant.

Epiphanies – Disclose at Your Discretion

Epiphanies – Disclose at Your Discretion

Apr 6

I’ve recently come to the conclusion that there are two kinds of epiphanies – the kind you like to brag about and the kind where you look around and say to yourself, “Am I the last person to figure this out?”

Let Bygones Be Bygones? Not So Fast

Let Bygones Be Bygones? Not So Fast

Mar 23 | Jonnatha Mayberry, Associate Editor

It seems that as humans, we are excellent at “temporary learning”: The art of correcting potentially reckless behavior after some event shakes us up, but then quickly reverting to our careless ways. 

Antibiotic Activism

Antibiotic Activism

Mar 22

I’m a big fan of those web stories that list 10 things your (insert name of profession) won’t tell you. From waiters to flight attendants to nurses – I’ve read them all – and most of their insights are not pretty.  

Correlation is Not Causation

Correlation is Not Causation

Mar 21 | Dr. Jamie Weiss, Senior Consultant, Kepner-Tregoe, Inc.

Seeking and finding correlations – co-occurrences between two or more factors – is a key tool in the root cause analysis arsenal. It can lead you to possible causal factors to investigate.

Just Business?

Just Business?

Mar 19

I typically use this space for talking about industry issues, offering my views and opinions on recent developments such as recalls and the recent drug shortage crisis. To me, that is just one side of the industry.

Neglected Tropical Disease (Infectious Diseases) Drugs: What are they telling us about Innovations!

Neglected Tropical Disease (Infectious Diseases) Drugs: What are they telling us about Innovations!

Mar 7 | Girish Malhotra, PE, EPCOT International

During my career I have been involved in process simplification and cost reduction of different chemistries, chemicals and processes. When I am discussing any process, my mind always races to understand its chemistry, manufacturing process and how the cost can be lowered and the profit improved.

Beyond Compliance: Using cGMP Compliance to Improve Business Results

Beyond Compliance: Using cGMP Compliance to Improve Business Results

Mar 5 | By John Ager, Consultant and Master Trainer for Kepner-Tregoe (KT)

Which organization is more like yours? FDA regulations will choke our business or compliance audits provide useful insights about what we can improve.

ARCHIVES
    2012    Jan • Feb • Mar • Apr • May 
    2011    Jan • Feb • Mar • Apr • May • June • July • Aug • Sept • Oct • Nov • Dec 
    2010    Jan • Feb • Mar • Apr • May • June • July • Aug • Sept • Oct • Nov • Dec 

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter